EZH2 and endothelial dysfunction: On the other hand, in case of low or absent FSS, e.g., in atheroprone arterial regions, high expression of EZH2 could contribute to endothelial dysfunction, e.g., by releasing endothelial cells from quiescence and promoting their (excessive) proliferation.